Experiment summary for ENCSR000EEQ
doi:10.17989/ENCSR000EEQ
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- PPARGC1A
- Biosample summary
- Homo sapiens HepG2 treated with 1 mM pyruvate for 6 hours, 1 μM forskolin for 6 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- PPARGC1A ChIP-seq on human HepG2 treated with forskolin
- Treatments
- 1 mM pyruvate (CHEBI:15361) for 6 hours, 1 μM forskolin (CHEBI:42471) for 6 hours
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
- Controls
Attribution
ENCODE2 project
- Lab
- Michael Snyder, Stanford
- Award
- U54HG004558 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Date submitted
- October 29, 2011
- Date released
- October 29, 2011
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
---|---|---|---|---|---|
1 | 1 | Homo sapiens HepG2 cell line treated with 1 mM pyruvate for 6 hours, 1 μM forskolin for 6 hours | ENCBS848AAA | ENCAB000AJW | ENCLB209AHP |
2 | 1 | Homo sapiens HepG2 cell line treated with 1 mM pyruvate for 6 hours, 1 μM forskolin for 6 hours | ENCBS848AAA | ENCAB000AJW | ENCLB209AHO |